Behavioral Neuroscience – News and Features

A new molecule could offer non-hormonal contraceptive options for people who produce sperm, according to new research published in The American Chemical Society (ACS)’s Journal of Medicinal Chemistry.

Editing healthy immune cells with CRISPR safely thwarts the brain's resistance to them, helping researchers to harness immune cell function to treat neurological conditions.

A preclinical study from Scripps Research has shown that an experimental antidepressant also shows promise as a treatment for alcohol use disorder.

An artificial intelligence program could accelerate the production of gene therapies by enabling the customizable production of zinc finger proteins that can turn genes on and off.

Turning a decades-old dogma on its head, a new study shows that the receptor for oxytocin, a hormone considered essential to forming social bonds, may not play the critical role that scientists have assigned to it for the past 30 years.

New research from the Institute of Psychiatry, Psychology & Neuroscience at King’s College London has established a blood-based test that could be used to predict the risk of Alzheimer’s disease up to 3.5 years before clinical diagnosis.

This article overviews the science behind the potential use of RRx-001as a “radiation buster” with anti-inflammatory and anti-free radical properties to prevent or reduce both GI-ARS and H-ARS.

A study shows that levodopa has the potential to reverse the effects of inflammation on brain reward circuitry, ultimately improving symptoms of depression.

Alcohol has complex, unseen and far-reaching effects at the molecular and cellular level, including altering our gut microbiome, accelerating the aging process and even changing the synapses in the brain.

With the world of science rapidly evolving, and a new year beginning, we looked at the trends breaking through right now, asking experts: where is the world of science headed?